Recombinant Human DOCK6 Protein，His

DOCK6 is a member of the dedicator of cytokinesis (DOCK) family of guanine nucleotide exchange factors (GEFs), which play a crucial role in regulating cytoskeletal dynamics and cellular movement by activating small GTPases, particularly Rac1. The research surrounding DOCK6 has gained prominence due to its significant implications in various biological processes, including neuronal development, immune response, and cell migration. Deficiencies or mutations in DOCK6 have been associated with severe disorders, such as myopathic congenital muscular dystrophy and the immune deficiency known as Wiskott-Aldrich syndrome. Investigating the structure and function of DOCK6, particularly its role in regulating Rac1 activation and downstream signaling pathways, has become a focal point in understanding its contribution to both normal physiological processes and pathological conditions. The reconstitution of DOCK6 in vitro is essential for dissecting its mechanistic roles and for the potential development of therapeutic strategies targeting diseases linked to its dysfunction. By producing and characterizing recombinant DOCK6, researchers aim to unveil its structural features and functional mechanisms, providing insights into how disturbances in its activity can lead to various health issues. The study of DOCK6 not only enhances our understanding of GEF interactions with GTPases but also presents opportunities for the development of novel interventions in diseases characterized by altered cell motility and immune responses. Thus, the comprehensive analysis of DOCK6 as a recombinant protein holds promise for both basic research and clinical advancements in treating related diseases.